377 related articles for article (PubMed ID: 25772644)
21. Eradication of multidrug-resistant Acinetobacter baumannii from the respiratory tract with inhaled colistin methanesulfonate: a matched case-control study.
Kuo SC; Lee YT; Yang SP; Chen CP; Chen TL; Hsieh SL; Siu LK; Fung CP
Clin Microbiol Infect; 2012 Sep; 18(9):870-6. PubMed ID: 21999321
[TBL] [Abstract][Full Text] [Related]
22. Early administration of appropriate antimicrobial agents to improve the outcome of carbapenem-resistant Acinetobacter baumannii complex bacteraemic pneumonia.
Park SY; Lee EJ; Kim T; Yu SN; Park KH; Lee MS; Park SY; Jeon MH; Kim TH; Choo EJ
Int J Antimicrob Agents; 2018 Mar; 51(3):407-412. PubMed ID: 29122697
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of nephrotoxicity and prognosis in patients treated with colistin due to hospital-acquired pneumonia.
Korkmaz Ekren P; Töreyin ZN; Berk Takır H; Kalamanoğlu Balcı M; Gaygısız Ü; Gürsel G; Ergan B; Yalçın A; Saltürk C; Aydoğdu M; Ergün R; Güven P; Ulubay G; Gürün Kaya A; Çeltik A; Uluer H; Bacakoğlu F; Sayıner A
Tuberk Toraks; 2017 Dec; 65(4):271-281. PubMed ID: 29631525
[TBL] [Abstract][Full Text] [Related]
24. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
[TBL] [Abstract][Full Text] [Related]
25. Intravenous and inhalational colistin-induced respiratory failure.
Wahby K; Chopra T; Chandrasekar P
Clin Infect Dis; 2010 Mar; 50(6):e38-40. PubMed ID: 20146630
[TBL] [Abstract][Full Text] [Related]
26. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
[TBL] [Abstract][Full Text] [Related]
27. The 21st-century challenge to neurocritical care: the rise of the superbug Acinetobacter baumannii. A meta-analysis of the role of intrathecal or intraventricular antimicrobial therapy in reduction of mortality.
Mohammed N; Savardekar AR; Patra DP; Narayan V; Nanda A
Neurosurg Focus; 2017 Nov; 43(5):E8. PubMed ID: 29088961
[TBL] [Abstract][Full Text] [Related]
28. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
[TBL] [Abstract][Full Text] [Related]
30. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
31. Incidence and Risk Factors for Colistin-Associated Nephrotoxicity.
Temocin F; Erdinc S; Tulek N; Demirelli M; Bulut C; Ertem G
Jpn J Infect Dis; 2015; 68(4):318-20. PubMed ID: 25720641
[TBL] [Abstract][Full Text] [Related]
32. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series.
Falagas ME; Siempos II; Rafailidis PI; Korbila IP; Ioannidou E; Michalopoulos A
Respir Med; 2009 May; 103(5):707-13. PubMed ID: 19118994
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
[TBL] [Abstract][Full Text] [Related]
35. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
[TBL] [Abstract][Full Text] [Related]
36. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
[TBL] [Abstract][Full Text] [Related]
37. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
38. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria.
Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V
J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621
[TBL] [Abstract][Full Text] [Related]
39. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Garnacho-Montero J; Amaya-Villar R; Gutiérrez-Pizarraya A; Espejo-Gutiérrez de Tena E; Artero-González ML; Corcia-Palomo Y; Bautista-Paloma J
Chemotherapy; 2013; 59(3):225-31. PubMed ID: 24356297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]